Nikhil

For small biotech and biopharma startups, the journey from an innovative idea to an approved drug is a marathon, not a sprint. The U.S. Food and Drug Administration (FDA) approval process is renowned for its complexity and the high stakes involved. It’s a daunting pathway that can determine whether a groundbreaking treatment reaches patients or